Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 February 2025 | Story Lacea Loader
University of the Free State Logo

On 12 February 2025, disruption of academic activities occurred on the Bloemfontein Campus of the University of the Free State (UFS); this followed the disruptions that occurred on 11 February 2025. On the Qwaqwa Campus, attempts to disrupt academic activities also occurred on 12 February 2024.

A memorandum of demands from the Institutional Student Representative Council (ISRC) was handed over to the university management on 11 February 2025, to which management responded; these demands are related to registration and funding. 

Financial concessions have been granted to students on two occasions so far this year to enable them to register. On 10 February 2025, the university granted follow-up concessions.

Furthermore, the institution’s Financial Working Group (FWG) – which includes representatives from the Institutional Student Representative Council (ISRC) – met regularly to determine how it could best assist students to register, taking into consideration the financial constraints of the university.

On the Bloemfontein Campus, 15 students were arrested on 12 February 2025 for transgression of the interdict; internal disciplinary processes are being instituted.

The university’s Protection Services has activated its protest management security escalation plan in accordance with the UFS Protest Management Policy; the situation on the campuses is being closely monitored.

All classes are continuing as normal, and no classes have been suspended. 

It is important to note the NSFAS-related progress made up until now: 

  • NSFAS funding has been confirmed and allocated to 25 551 students.
  • 22 246 of these students have already been successfully registered for the academic year.
  • NSFAS allowances were paid to 14 303 registered students on 3 February 2025.
  • On 17 February 2025, interim allowances will be paid to 7 943 students who were not registered at the time of the first round of payments.
Financial concessions have been granted to students during two occasions so far this year. On 10 February 2025, the university granted the following follow-up concessions: 

1. NSFAS-funded students

Criteria:

  • NSFAS funding for 2025 must be confirmed and reflected on the acknowledgement of debt (AOD) or registration verification document.
  • Historic debt may not exceed R35 000.

Concessions:

  • No payment is required.
  • Students will be eligible for full registration.

Criteria: 

  • NSFAS funding for 2025 must be confirmed and reflected on the acknowledgement of debt (AOD) or registration verification document.
  • Historic debt exceeding R35 000 but not exceeding R50 000.
      Concessions:
  • No payment is required.
  • Students will be eligible for provisional registration. Provisional registration applications must be submitted, and all other terms and conditions will apply.
2. Returning self-paying South African students:

Criteria:
  • Historic debt must not exceed R35 000.
  • Must sign an acknowledgment of debt (AOD).
Concessions:
  • No payment is required.
  • Students will be eligible for provisional registration. Provisional registration applications must be submitted, and all other terms and conditions will apply.
3. Final-year students:
  • Students with an average mark of above 60% were assisted with Monitoring bursaries.
  • 2025 final-year students with an average mark of between 50% and 60% will be assisted with the following concessions.  
Criteria:
  • Final-year students with a pass rate of between 50 and 60% and with outstanding fees up to a maximum of R60 000 to register provisionally.
Concessions:
  • No payment is required.
  • Students must complete a provisional registration application and attach an AOD, covering historic debt plus the first payment required for 2025 registration. 
4. Postgraduate students 
  • The Department of Finance is in contact with the Centre for Postgraduate Support to fast-track funding confirmations.
  • Postgraduate students who have studied at other institutions and wish to register at the UFS must contact Student Finance for possible assistance with registration.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept